Skip to Content
Merck

Amyloid-Beta Mediates Homeostatic Synaptic Plasticity.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2021-05-01)
Christos Galanis, Meike Fellenz, Denise Becker, Charlotte Bold, Stefan F Lichtenthaler, Ulrike C Müller, Thomas Deller, Andreas Vlachos
ABSTRACT

The physiological role of the amyloid-precursor protein (APP) is insufficiently understood. Recent work has implicated APP in the regulation of synaptic plasticity. Substantial evidence exists for a role of APP and its secreted ectodomain APPsα in Hebbian plasticity. Here, we addressed the relevance of APP in homeostatic synaptic plasticity using organotypic tissue cultures prepared from APP -/- mice of both sexes. In the absence of APP, dentate granule cells failed to strengthen their excitatory synapses homeostatically. Homeostatic plasticity is rescued by amyloid-β and not by APPsα, and it is neither observed in APP+/+ tissue treated with β- or γ-secretase inhibitors nor in synaptopodin-deficient cultures lacking the Ca2+-dependent molecular machinery of the spine apparatus. Together, these results suggest a role of APP processing via the amyloidogenic pathway in homeostatic synaptic plasticity, representing a function of relevance for brain physiology as well as for brain states associated with increased amyloid-β levels.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Biocytin, ≥98% (TLC)
Sigma-Aldrich
β-Secretase Inhibitor IV, β-Secretase Inhibitor IV, CAS 797035-11-1, is a cell-permeable inhibitor that binds to BACE-1 active site and blocks its proteolytic activity (IC₅₀ = 15 nM for human BACE-1).